187 related articles for article (PubMed ID: 37702275)
21. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment.
Jiang YH; Jhang JF; Lee YK; Kuo HC
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203604
[TBL] [Abstract][Full Text] [Related]
22. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
23. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
24. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
26. New Frontiers or the Treatment of Interstitial Cystitis/Bladder Pain Syndrome - Focused on Stem Cells, Platelet-Rich Plasma, and Low-Energy Shock Wave.
Lin CC; Huang YC; Lee WC; Chuang YC
Int Neurourol J; 2020 Sep; 24(3):211-221. PubMed ID: 33017892
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an
Kuret T; Peskar D; Kreft ME; Erman A; Veranič P
Front Immunol; 2022; 13():960667. PubMed ID: 36045687
[TBL] [Abstract][Full Text] [Related]
28. Current Understanding of the Pathophysiology and Novel Treatments of Interstitial Cystitis/Bladder Pain Syndrome.
Jhang JF; Jiang YH; Kuo HC
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289642
[TBL] [Abstract][Full Text] [Related]
29. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
Jhang JF
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
[TBL] [Abstract][Full Text] [Related]
30. The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models.
van Ginkel C; Hurst RE; Janssen D
Curr Opin Urol; 2024 Mar; 34(2):77-83. PubMed ID: 37933666
[TBL] [Abstract][Full Text] [Related]
31. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study.
Mishra NN; Riedl C; Shah S; Pathak N
Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739
[TBL] [Abstract][Full Text] [Related]
32. Urothelial health after platelet-rich plasma injection in intractable recurrent urinary tract infection: Improved cell proliferation, cytoskeleton, and barrier function protein expression.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Lin TY; Birder LA; Kuo HC
Low Urin Tract Symptoms; 2021 Apr; 13(2):271-278. PubMed ID: 33197967
[TBL] [Abstract][Full Text] [Related]
33. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
Meng E; Hsu YC; Chuang YC
Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
[TBL] [Abstract][Full Text] [Related]
34. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
Chuang YC; Chermansky C; Kashyap M; Tyagi P
Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
[TBL] [Abstract][Full Text] [Related]
35. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model.
Chueh KS; Huang KH; Lu JH; Juan TJ; Chuang SM; Lin RJ; Lee YC; Long CY; Shen MC; Sun TW; Juan YS
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628581
[TBL] [Abstract][Full Text] [Related]
37. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
38. Platelet-Rich Plasma Ameliorates Cyclophosphamide-Induced Acute Interstitial Cystitis/Painful Bladder Syndrome in a Rat Model.
Chen YH; Man KM; Chen WC; Liu PL; Tsai KS; Tsai MY; Wu YT; Chen HY
Diagnostics (Basel); 2020 Jun; 10(6):. PubMed ID: 32521683
[TBL] [Abstract][Full Text] [Related]
39. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
40. The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans.
Mormone E; Cisternino A; Capone L; Caradonna E; Sbarbati A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
